Previous Close | 0.0060 |
Open | 0.0076 |
Bid | 0.0000 x N/A |
Ask | 0.0000 x N/A |
Day's Range | 0.0076 - 0.0076 |
52 Week Range | 0.0060 - 0.0506 |
Volume | |
Avg. Volume | 3,831 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Three months post cessation of an 8-week course of microdosing treatment, the antidepressant response is sustained with a 62.8% reduction in depressive symptoms. VANCOUVER, BC / ACCESSWIRE / August 19, 2024 /MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), ...
VANCOUVER, BC / ACCESSWIRE / August 1, 2024 /MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), a leading biopharmaceutical company in psychiatric medicine development, is pleased to report that it has appointed Haywood ...